Search tips
Search criteria 


Logo of canfamphysLink to Publisher's site
Can Fam Physician. 1997 May; 43: 941–945.
PMCID: PMC2255515

What information do physicians receive from pharmaceutical representatives?


OBJECTIVE: To assess the information pharmaceutical sales representatives provide to physicians. DATA SOURCES: A MEDLINE search from January 1966 to May 1996 was done using combinations of the terms pharmaceutical industry, drug information services, drug utilization, physician's practice patterns and prescriptions, and drugs. Studies identified from this search were supplemented by material from my personal library. STUDY SELECTION: Studies had to be conducted in industrialized countries, based on direct observations of actual physician and sales representative contacts, and reporting quantitative results on the quality of information transmitted. SYNTHESIS: Four studies were included. Representatives usually mentioned the indications for their drugs, but omitted safety information. Representatives' information frequently contained inaccuracies. CONCLUSION: Sales representatives present only selected, usually positive, information about their products. Canadian doctors should not be passive recipients of information provided by sales representatives. Physicians who choose to continue to see representatives must critically compare the information they get from them with that contained in scientific publications.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (962K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Shin JH, Haynes RB, Johnston ME. Effect of problem-based, self-directed undergraduate education on life-long learning. CMAJ. 1993 Mar 15;148(6):969–976. [PMC free article] [PubMed]
  • Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, McKinney WP. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990 May-Jun;5(3):240–243. [PubMed]
  • Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ. 1995 Sep 1;153(5):553–559. [PMC free article] [PubMed]
  • Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med. 1988;26(12):1183–1189. [PubMed]
  • Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994 Mar 2;271(9):684–689. [PubMed]
  • Gordon M. "Disinformation" from pharmaceutical company representatives. CMAJ. 1990 Jun 1;142(11):1177–1178. [PMC free article] [PubMed]
  • Hemminki E. Content analysis of drug-detailing by pharmaceutical representatives. Med Educ. 1977 May;11(3):210–215. [PubMed]
  • Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995 Apr 26;273(16):1296–1298. [PubMed]
  • Becker MH, Stolley PD, Lasagna L, McEvilla JD, Sloane LM. Differential education concerning therapeutics and resultant physician prescribing patterns. J Med Educ. 1972 Feb;47(2):118–127. [PubMed]
  • Bower AD, Burkett GL. Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices. J Fam Pract. 1987 Jun;24(6):612–616. [PubMed]
  • Spingarn RW, Berlin JA, Strom BL. When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med. 1996 Jan;71(1):86–88. [PubMed]
  • Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996 Apr;5(4):201–206. [PubMed]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada